RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · SPECIFICATIONS AND PRICES REQUIRE FINAL CONFIRMATION
Research Library

PEPTIDES BIO / RESEARCH MODELS & EVIDENCE

MOTS-C Nuclear Localization During Metabolic Stress: HEK293 Cell Records

A source-limited MOTS-C record of HEK293 metabolic-stress localization, AMPK comparisons, and nuclear measurements from PMID 29983246.

Published Published byPeptides Bio

Research or raw-material evaluation only. Not for human or veterinary use.

Related research material

MOTS-C 20mg is the related catalogue material. The primary study below reports defined cell systems and experimental measurements; it does not identify a catalogue lot or report an analytical result for a separately supplied vial.

Research use only. This article summarizes a published cell-study record and does not provide medical, veterinary, dosing, administration, safety, or outcome guidance.

Study question and source scope

Kim et al. examined whether mitochondrial-encoded MOTS-c could localize to the nucleus and participate in nuclear gene-expression measurements during cellular metabolic stress [1]. The paper is a defined cell-study record. Its conclusions concern the cell lines, stress conditions, comparisons, time points, and assays reported by its authors; they do not establish a result for a catalogue material or for a different experimental system. The reported experiments are not a product comparison or an analytical characterization.

The name MOTS-c had previously been reported by Lee et al. for a 16-amino-acid peptide encoded by a short open reading frame within mitochondrial 12S rRNA [2]. That earlier identity record explains the term used by Kim et al. It does not substitute for the 2018 paper’s cell methods or nuclear measurements.

Resting HEK293 localization measurements

Kim et al. first studied endogenous MOTS-c in resting HEK293 cells. Figure 1 reports immunoblots of whole-cell, cytoplasmic, nuclear, and mitochondrial fractions; immunofluorescence microscopy; and immunoblotting of increasing amounts of nuclear extract [1]. The authors used neutralizing-peptide competition to test antibody specificity in the nuclear-extract measurement. These assays supplied separate fractionation, imaging, and immunoblot readouts rather than one interchangeable localization result.

The same figure also describes an EGFP-tagged MOTS-c construct examined by confocal microscopy and subcellular-fraction immunoblotting. The authors compared the wild-type sequence with two alanine-substitution constructs, one covering residues 8YIFY11 and one covering residues 13RKLR16. Their reported nuclear-localization comparison belongs to those tagged constructs in HEK293 cells. It does not identify the sequence, structure, or composition of a separately supplied material.

Metabolic-stress time course in HEK293 cells

For the stress experiment, Kim et al. used HEK293 cells under glucose restriction, serum deprivation, or tert-butyl hydrogen peroxide conditions [1]. They collected subcellular fractions at 0, 0.5, 1, 3, 6, and 24 hours after the stated stress condition and acquired confocal images at the 3-hour point. The authors report nuclear MOTS-c detection as early as 30 minutes and a return toward predominantly extra-nuclear localization within 24 hours. Those observations are a time-resolved finding in the reported HEK293 comparison.

Figure 2 pairs the fractionation and imaging measurements with reactive-oxygen-species measurements by flow cytometry and fluorescence-activated cell sorting. The same figure includes control conditions for the mitochondrial reactive-oxygen-species measurement. Each method answers a different question: subcellular fractionation and microscopy locate the measured signal, while the flow-based assays report the specified reactive-oxygen-species readouts. The supplementary figures report similar stress-associated localization observations in HepG2 cells, but they do not make HEK293 and HepG2 interchangeable systems. The paper does not present these measurements as a test of a commercial lot.

AMPK comparison in the reported cell system

The authors tested AMPK involvement with a pharmacologic inhibitor and with siRNA directed against AMPKalpha, each compared with its stated control, before the stress conditions [1]. They assessed nuclear MOTS-c by fractionation immunoblotting and by immunofluorescence. Kim et al. report that these AMPK-inhibition comparisons prevented the stress-associated nuclear translocation measured in their HEK293 system. This is an author-reported comparison result, limited to the stated interventions, cell line, and readouts.

The source also reports nuclear-localization measurements after the authors used two separate AMPK-activating experimental conditions. Because those conditions are part of the paper’s cell protocol, they are not reproduced here as a protocol or a recommendation. The relevant research fact is the reported comparison design: the authors assessed whether AMPK-directed perturbations changed the nuclear-location measurement in HEK293 cells.

Nuclear measurements after stress

Kim et al. next examined chromatin-associated and nuclear measurements. For HEK293 cells under glucose restriction or tert-butyl hydrogen peroxide stress, they used immunoblotting of chromatin extracts, co-immunoprecipitation from nuclear extracts, electrophoretic mobility-shift assays, and ChIP-qPCR [1]. The ChIP-qPCR comparison reports promoter regions containing antioxidant response elements for HO-1 and NQO1 at 0, 3, and 24 hours after the stated stress conditions.

The paper also reports an RNA-seq comparison in HEK293 cells transfected with a MOTS-c construct or an empty-vector control and then subjected to glucose restriction for 3 hours. The authors describe differentially regulated genes and transcription-factor-motif analyses within that transfection-and-stress comparison. These readouts do not establish equivalent gene-expression findings in untransfected cells, another cell line, an animal model, or a catalogue material.

The study’s comparison structure remains visible across its figures: basal HEK293 fraction measurements differ from the stress time course; the AMPK-inhibition comparisons differ from the construct and empty-vector comparisons; and the chromatin assays differ from RNA-seq. Kim et al. provide the relevant method and control for each of these observations. A result from one comparison cannot supply an unreported control, time point, or assay for another.

Model boundary

PMID 29983246 supports a narrow claim: in its named cell experiments, Kim et al. measured MOTS-c localization and nuclear-associated readouts under defined metabolic-stress comparisons. It does not report a batch certificate, purity result, stability result, receiving record, or a link between the experimental peptide and MOTS-C 20mg. It also does not establish a human or veterinary use outcome.

MOTS-C: Classifying Evidence by Research Model provides a separate overview of broader model categories. The record here remains limited to the HEK293 cell conditions, time course, comparison groups, and nuclear measurements reported in PMID 29983246.

References

  1. Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. 2018;28(3):516-524.e7. PMID 29983246.
  2. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454. PMID 25738459.

Need a product record?

Build a structured request.

Browse materials